- AdventHealth
In Medscape’s most recent Physician Burnout & Depression Report, 49 percent of U.S. physicians surveyed across 29 specialties said they felt burned out. Left unaddressed, burnout can erode physicians’ mental health, and according to the National Academy of Medicine, the high prevalence of physician burnout poses an under-recognized threat to the delivery of safe, high-quality health care.
AdventHealth Research Institute is currently seeking physicians experiencing exhaustion, irritability, hopelessness, anxiety, work/home imbalance or similar burnout symptoms to participate in a research study called RISE for Physicians. An evidence-based, 2.5-day retreat-style well-being intervention led by licensed mental health care professionals, it builds off the success of a similar program developed for and implemented with AdventHealth nurses and nurse leaders.
RISE focuses on four themes: Resilience, Insight, Self-compassion and Empowerment. During the retreat, physicians will learn self-care knowledge and skills while also processing emotional experiences and sharing with colleagues in a non-judgmental environment.
Enrollment in RISE for Physicians is open to AdventHealth employed, contract or non-employed physicians (MD or DO) with AdventHealth privileges. They can choose to attend one of three scheduled programs in Central Florida in September, October, or November 2024. Although travel costs will not be reimbursed, food and lodging during the study will be covered, and compensation will be provided for completion of the entire study.
Battling the Physician Burnout Epidemic and Its Impacts
Burnout has been defined as long-term, unresolved, job-related stress leading to exhaustion, cynicism, depersonalization and decline in a sense of personal accomplishment. For physicians, this has been attributed to increasing obstacles and daily demands of the profession, including administrative burdens, insurance authorization and payment challenges, and reduced time spent on direct delivery of patient care.
Cross sectional studies of physicians have found burnout to be independently associated with increased alcohol use/dependence and suicide. Numerous studies have also documented the negative impacts physician burnout has on quality of care and safety, patient satisfaction and physician turnover.
“Despite all of these harms, there has been little research on effective interventions for physicians,” says Amanda Sawyer, PhD, AdventHealth Research Institute Biobehavioral Research Scientist and Principal Investigator of RISE for Physicians. “With the RISE for Physicians study, we aim to change that.”
Michael Cacciatore, MD, AdventHealth Chief Clinical Officer and Executive Sponsor of the RISE for Physicians study concurs. “While the concept of burnout is not new, it grew significantly during the COVID-19 pandemic and remains high today. As an organization focused on delivering whole-person health, we know this is an epidemic AdventHealth must address. I encourage physicians who may be struggling with burnout to explore this unique opportunity designed to improve their well-being.”
More About RISE for Physicians
A burnout intervention initially developed as an 8-week program for nurses, RISE provides education to improve coping and well-being by addressing the underlying causes and effects of high stress, burnout and compassion fatigue while also offering support and facilitation to heal existing stress injuries. It was first piloted with AdventHealth direct care nurses in 2018, and in 2019, a randomized controlled trial was conducted. The program was then adapted for unit-based nurse leaders during the COVID-19 pandemic and piloted during the height of the Delta surge in 2021. In 2022, the AdventHealth Research Institute conducted a randomized controlled trial with nurse managers and assistant nurse managers.
All four studies demonstrated feasibility and statistically significant improvements in well-being outcomes, including those related to the four RISE program themes along with post-traumatic growth, professional quality of life and perceived stress.
“We have empirical support for RISE with nurses, and using the same foundation and framework, we have adapted the program for a physician population, consolidating it into an intensive 2.5 day retreat-style intervention,” states AdventHealth Research Institute Psychotherapist and Research Scientist Mandi Bailey, MA, LMHC, RISE developer and sub-investigator for the RISE research studies. “RISE is unique in that it is grounded in therapeutic best practices that integrate mindfulness, acceptance and commitment therapy, and cognitive-behavioral therapy.
To evaluate the effectiveness of RISE for Physicians, the research team will measure several indicators of the physician participants’ mental well-being using pre-intervention surveys followed by post-intervention surveys at both 1 month and 3 months after the retreat. Specific outcomes include post-traumatic growth, resilience, insight, self-compassion, empowerment, perceived stress, burnout and professional quality of life.
The RISE for Physicians research team expects to report initial results of the study in early 2025.
Physicians interested in enrolling in the RISE for Physicians study should visit https://forms.office.com/r/3u3HBpppRA.
Recent News
AdventHealth Cancer Institute Advances the Use of CAR T-Cell Therapy for Multiple Myeloma
CAR-T therapies have emerged as new treatment options for certain types of cancer through a one-time infusion that can lead to long-lasting remission.
New Clinical Trial Explores Digital Intervention for Apathy in Late-life Depression
Afflicting 30-50% of patients with late-life depression, apathy is a challenging psychiatric syndrome in older adulthood that can result in lack of motivation leading to poor self-care, physical...
AdventHealth Performs Central Florida’s First Liver Transplant for Unresectable Colorectal Liver Metastases
In June 2025, AdventHealth Abdominal Transplant Surgeon and Surgical Oncologist Ryan Day, MD, worked with a multidisciplinary team to perform Central Florida’s first liver transplant for unresectable...
AdventHealth Neuroscience Institute First in Florida to be Recognized as a GammaTile Center of Excellence
GammaTile is the first and only tile-based radiation therapy for the treatment of
operable brain tumors. The AdventHealth Neuroscience Institute began performing GammaTile procedures in 2021 and was...
An AdventHealth Collaboration Explores the Impact of Microgravity and Electrical Stimulation on Muscle Cell Health in Space
Using a muscle lab-on-chip model aboard the International Space Station (ISS), AdventHealth Translational Research Institute’s Dr. Paul Coen has been working with a multidisciplinary team from the...
AdventHealth Neuroscience Institute Among First in U.S. to Offer Phase IIa Clinical Trial of Troculeucel for Moderate Alzheimer’s Disease
While most clinical trials for Alzheimer’s disease have focused on patients with early or mild cognitive impairment, roughly 30% of those with Alzheimer’s have moderate stage disease for which there...
AdventHealth Translational Research Institute Selected as Clinical Site for National Study of Muscle, Mobility and Aging (SOMMA)
Under the leadership of Scientific Director and Principal Investigator Bret H. Goodpaster, PhD, the AdventHealth Translational Research Institute (TRI) is now enrolling men and women 70 years of age...
AdventHealth Neuroscience Institute Administers First Dose of Investigative NK Cell Therapy to Person with Alzheimer’s Disease
Under a single compassionate use Investigational New Drug (IND) authorization cleared by the U.S. Food and Drug Administration (FDA), the AdventHealth Neuroscience Institute worked with NKGen Biotech...
AdventHealth Study Exploring the Use of MR-Guided Focused Ultrasound (MRgFUS) to Disrupt the Blood-Brain Barrier for Treatment of Alzheimer’s Disease
Under the leadership of Dr. Valeria Baldivieso and Dr. Chandan Reddy, the AdventHealth Research Institute is the first and only site in Orlando offering the Exablate Blood-Brain Barrier (BBB)...
AdventHealth Research Institute Offers Phase II Clinical Trial of Etanercept for Treatment of Blast-Induced Tinnitus
Approximately 1 billion people throughout the world suffer from tinnitus (ringing in the ears), and it is the number one disability of those who serve in the U.S. military. The condition can disrupt...
AdventHealth Research Institute and NESTRE Health & Performance Announce Collaboration to Advance Neurocognitive Health and Performance Through Cognitive Training
With an aging population and increases in the prevalence of neurological conditions like Alzheimer’s disease and dementia, physicians and patients alike continue to seek new tools and approaches to...
AdventHealth Among First in U.S. to Offer IDP023-2-101 Clinical Trial for Patients with Progressive Multiple Sclerosis
The AdventHealth Neuroscience Institute is the first in Florida and one of the first in the country to begin recruiting patients with primary progressive or non-active secondary progressive multiple...